Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis (Q46583319)

23 December 2017

title

Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis (English)

1 reference

23 December 2017

0 references

6

1 reference

23 December 2017

author name string

D Michalska

1

1 reference

23 December 2017

M Luchavova

2

1 reference

23 December 2017

V Zikan

3

1 reference

23 December 2017

I Raska

4

1 reference

23 December 2017

A A Kubena

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

17 March 2012

1 reference

23 December 2017

Osteoporosis International

published in

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

12

1 reference

23 December 2017

page(s)

2885-2891

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00198-012-1955-4

exact match

0 references

cites work

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

The use of parathyroid hormone in the treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Structural and geometric changes in iliac bone: relationship to normal aging and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1955-4

Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis

21 January 2018

1 reference

12 December 2020

The effect of calcium supplementation on the circadian rhythm of bone resorption

1 reference

12 December 2020

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos

1 reference

12 December 2020

The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis

1 reference

12 December 2020

Circadian and circatrigintan changes in osteoblastic activity assessed by serum osteocalcin. Physiological and methodological aspects.

1 reference

12 December 2020

The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis

1 reference

12 December 2020

10.1007/S00198-012-1955-4

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

22426952

1 reference

23 December 2017